[X-linked adrenoleukodystrophy (X-ALD)].
M
M
Fenchel
A
A
Korn
T
T
Nägele
U
U
Ernemann
M
M
Horger
D000074063:ATP Binding Cassette Transporter, Subfamily D, Member 1; D018528:ATP-Binding Cassette Transporters / Q000235:genetics; D000326:Adrenoleukodystrophy / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D000818:Animals; D001479:Basal Ganglia / Q000473:pathology; D002552:Cerebral Ventricles / Q000473:pathology; D002648:Child; D004252:DNA Mutational Analysis; D057210:Delayed Diagnosis; D003937:Diagnosis, Differential; D038524:Diffusion Magnetic Resonance Imaging; D004195:Disease Models, Animal; D018450:Disease Progression; D004338:Drug Combinations; D004883:Erucic Acids / Q000627:therapeutic use; D006801:Humans; D007089:Image Enhancement; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D009413:Nerve Fibers, Myelinated / Q000473:pathology; D009460:Neurologic Examination; D010641:Phenotype; D012680:Sensitivity and Specificity; D014304:Triolein / Q000627:therapeutic use
C115572:ABCD1 protein, human; D000074063:ATP Binding Cassette Transporter, Subfamily D, Member 1; D018528:ATP-Binding Cassette Transporters; D004338:Drug Combinations; D004883:Erucic Acids; C079420:Lorenzo's oil; D014304:Triolein